#Cannabisstocks - ALGAE DYNAMICS CORP (OTC: $ADYNF)
SECURES BULK #CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS
TORONTO, Aug. 02, 2018 –(Investorideas.com Newswire) ALGAE DYNAMICS CORP (OTC: ADYNF) (the
"Company"), a company focused on the development of unique health
products and nutraceuticals utilizing cannabis and botanical oil extracts, has
secured a supply agreement to enable Canadian Licensed Producers and
International Licensed Importers access to bulk cannabis deliveries in
anticipation of licensing agreements for our proprietary Cannabis formulated
products.
Read this in full at http://www.investorideas.com/news/2018/cannabis/08021OTCADYNF.asp
Recent Developments in our Collaboration with Western University
The researchers at Western University, the Company’s
scientific collaboration team, have developed a very unique formulation
involving cannabis and other botanical extracts. Western University’s Dr.
Laviolette said, “We are pleased to report significant progress on our ongoing
projects with Algae Dynamics. We are continuing to work out the precise
molecular mechanisms underlying the therapeutic modes of action for several
unique cannabinoid formulations. These research projects are identifying safer
and clinically superior cannabinoid formulations aimed at treating the symptoms
of various psychiatric disorders, while eliminating the negative side effects
associated with traditional marijuana formats.”
The invention will be assigned to Algae Dynamics Corp.
free from any royalties and will become 100% owned by the company.
We are in the process of filing a patent application
prior to entering into domestic and international distribution agreements with
Licensed Producers/Dealers (LPs/LDs) and Pharmaceutical companies.
Our discussions with the perspective LP’s/LD’s have
included the production, distribution and related collaborative initiatives
involving our specially formulated products.
We have an assignable supply agreement with a
large-volume, high-quality cannabis grower to secure a source of cannabis
material for our Licensed Partners producing and selling our Medical Cannabis
formulations.
We expect to generate revenue in 2018 from our
agreements with our Licensed Partners.
Paul Ramsay stated, “We are pleased that we can
further support Dr. Steven Laviolette and his team at Western University by
securing a high-quality and high-volume supply of Medical Cannabis for
formulations applicable to mental health conditions.”
About Dr. Steven Laviolette
The investigator leading the research is Dr. Steven
Laviolette, a Professor and Neuroscientist in the Schulich School of Medicine
& Dentistry at Western University in London, Ontario. Dr. Laviolette is a
leader in the study of cannabinoids in mental health and was recently awarded
“Faculty Scholar” status at Western University. Dr. Laviolette’s research team
has previously made numerous fundamental discoveries related to how
cannabinoids impact and may serve as treatments for mental health disorders
including schizophrenia, depression, post-traumatic stress disorder and
anxiety. Dr. Laviolette’s primary research focus is in characterizing how
specific phytochemical derivatives of cannabis may interact with specific brain
pathways and molecular mechanisms whereby they may improve symptoms associated
with various mental health disorders. Research from Dr. Laviolette’s team has
been published in the top neuroscience and psychiatry journals in the world.
His full profile may be seen on Western University’s, website www.uwo.ca
About Algae Dynamics Corp (ADC)
ADC is engaged in the development of unique health
products and nutraceuticals that utilize hemp, cannabis and algae oils. We have
engaged two Canadian universities to provide research into the use of extracts
from cannabis oil, which we plan to use to develop products that combine the
significant health benefits of Omega-3s derived from algae oil and extracts
from cannabis oil. Our research is focused on the use of cannabis oil in the
context of cancer, and the use of cannabis derivatives for the development of
novel pharmacotherapies for mental health.
For more information, visit http://www.algaedynamics.com
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking
statements" as that term is defined in Section 27A of the Securities Act
and Section 21E of the Securities Exchange Act of 1934, as amended. Statements
in this press release which are not purely historical are forward-looking
statements and include any statements regarding beliefs, plans, expectations or
intentions regarding the future. Such forward-looking statements include, among
other things, use of proceeds and the development, costs and results of current
or future actions and opportunities in the sector. Actual results could differ
from those projected in any forward-looking statements due to numerous factors.
Such factors include, among others, the inherent uncertainties associated with
new projects and development stage companies, our ability to raise the
additional funding we will need to continue to pursue our exploration and
development program, and our ability to retain important members of our
management team and attract other qualified personnel. These forward-looking
statements are made as of the date of this news release, and we assume no
obligation to update the forward-looking statements, or to update the reasons
why actual results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there can be no
assurance that any such beliefs, plans, expectations or intentions will prove
to be accurate.
Investors should consult all the information set forth
herein and should also refer to the risk factors disclosure outlined in our
annual report on Form 10-K for the most recent fiscal year, our quarterly
reports on Form 10-Q and other periodic reports filed from time-to-time with
the Securities and Exchange Commission.
This news is
published on the Investorideas.com Newswire - a global digital news source for
investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC
Residents and global Investors: Effective September 15 2008 - all BC investors
should review all OTC and Pink sheet listed companies for adherence in new
disclosure filings and filing appropriate documents with Sedar. Read for more
info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Please read Investorideas.com
privacy policy: http://www.investorideas.com/About/Private_Policy.asp
